SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

被引：2

作者：

Perez-Fidalgo, Jose Alejandro ^{[1
]}

Galvez-Montosa, Fernando ^{[2
]}

Guerra, Eva Maria ^{[3
]}

Madariaga, Ainhoa ^{[4
]}

Manzano, Aranzazu ^{[5
]}

Martin-Lorente, Cristina ^{[6
]}

Rubio-Perez, Maria Jesus ^{[7
]}

Alarcon, Jesus ^{[8
]}

Barretina-Ginesta, Maria Pilar ^{[9
]}

Gaba, Lydia ^{[10
]}

机构：

[1] Univ Valencia, Hosp Clin Univ, Biomed Res Inst INCL, Valencia, Spain

[2] Hosp Univ Jaen, Jaen, Spain

[3] Hosp Univ Ramon y Cajal, Madrid, Spain

[4] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain

[5] Hosp Clin San Carlos, Madrid, Spain

[6] Hosp Santa Creu & Sant Pau, Radiol, Barcelona, Spain

[7] Univ Cordoba UCO, Hosp Univ Reina Sofia, Cordoba, Spain

[8] Hosp Univ Son Espases, Mallorca, Spain

[9] Univ Girona, Inst Invest Biomed Girona IDIBGI, Med Sci Dept, Inst Catala Oncol,Med Oncol Dept,Precis Oncol Grp, Girona, Spain

[10] Univ Barcelona, Hosp Clin, Translat Genom & Targeted Therapies Solid Tumors, Med Oncol Dept,IDIBAPS,Dept Med, Barcelona, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Ovarian cancer; Guideline; Diagnosis; Treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; OPEN-LABEL; MAINTENANCE THERAPY; DOUBLE-BLIND; SECONDARY CYTOREDUCTION; PLUS BEVACIZUMAB; RECURRENT; CHEMOTHERAPY; MULTICENTER; OLAPARIB;

D O I：

10.1007/s12094-024-03531-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.

引用

页码：2758 / 2770

页数：13

共 50 条

[21] SEOM clinical guideline for treatment of kidney cancer (2017)
Gallardo, E.
Mendez-Vidal, M. J.
Perez-Gracia, J. L.
Sepulveda-Sanchez, J. M.
Campayo, M.
Chirivella-Gonzalez, I.
Garcia-del-Muro, X.
Gonzalez-del-Alba, A.
Grande, E.
Suarez, C.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 47 - 56
[22] SEOM clinical guideline on hereditary colorectal cancer (2019)
C. Guillén-Ponce
E. Lastra
I. Lorenzo-Lorenzo
T. Martín Gómez
R. Morales Chamorro
A. B. Sánchez-Heras
R. Serrano
M. C. Soriano Rodríguez
J. L. Soto
L. Robles
Clinical and Translational Oncology, 2020, 22 : 201 - 212
[23] SEOM clinical guideline for treatment of kidney cancer (2019)
Lazaro, M.
Valderrama, B. P.
Suarez, C.
de-Velasco, G.
Beato, C.
Chirivella, I.
Gonzalez-del-Alba, A.
Lainez, N.
Mendez-Vidal, M. J.
Arranz, J. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 256 - 269
[24] SEOM clinical guideline on unknown primary cancer (2017)
F. Losa
G. Soler
A. Casado
A. Estival
I. Fernández
S. Giménez
F. Longo
R. Pazo-Cid
J. Salgado
M. Á. Seguí
Clinical and Translational Oncology, 2018, 20 : 89 - 96
[25] SEOM Clinical Guideline of localized rectal cancer (2016)
E. González-Flores
F. Losa
C. Pericay
E. Polo
S. Roselló
M. J. Safont
R. Vera
J. Aparicio
M. T. Cano
C. Fernández-Martos
Clinical and Translational Oncology, 2016, 18 : 1163 - 1171
[26] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
Vera, R.
Dotor, E.
Feliu, J.
Gonzalez, E.
Laquente, B.
Macarulla, T.
Martinez, E.
Maurel, J.
Salgado, M.
Manzano, J. L.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1172 - 1178
[27] SEOM clinical guideline for treatment of kidney cancer (2017)
E. Gallardo
M. J. Méndez-Vidal
J. L. Pérez-Gracia
J. M. Sepúlveda-Sánchez
M. Campayo
I. Chirivella-González
X. García-del-Muro
A. González-del-Alba
E. Grande
C. Suárez
Clinical and Translational Oncology, 2018, 20 : 47 - 56
[28] SEOM clinical guideline for treatment of cancer pain (2017)
C. Jara
S. del Barco
C. Grávalos
S. Hoyos
B. Hernández
M. Muñoz
T. Quintanar
J. A. Meana
C. Rodriguez
R. de las Peñas
Clinical and Translational Oncology, 2018, 20 : 97 - 107
[29] SEOM clinical guideline on unknown primary cancer (2017)
Losa, F.
Soler, G.
Casado, A.
Estival, A.
Fernandez, I.
Gimenez, S.
Longo, F.
Pazo-Cid, R.
Salgado, J.
Segui, M. A.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01): : 89 - 96
[30] Clinical guideline SEOM: cancer of unknown primary site
R. Collado Martín
A. García Palomo
L. de la Cruz Merino
P. Borrega García
F. J. Barón Duarte
Clinical and Translational Oncology, 2014, 16 : 1091 - 1097

← 1 2 3 4 5 →